Proadrenomedullin in the Management of COVID-19 Critically Ill Patients in Intensive Care Unit: A Systematic Review and Meta-Analysis of Evidence and Uncertainties in Existing Literature

Mid-regional proadrenomedullin (MR-proADM) is a new biomarker of endothelial damage and its clinical use is increasing in sepsis and respiratory infections and recently in SARS-CoV-2 infection. We conducted a systematic review and meta-analysis to clarify the use of MR-proADM in severe COVID-19 dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Montrucchio, Giorgia, Balzani, Eleonora, Lombardo, Davide, Giaccone, Alice, Vaninetti, Anna, D’Antonio, Giulia, Rumbolo, Francesca, Mengozzi, Giulio, Brazzi, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369672/
https://www.ncbi.nlm.nih.gov/pubmed/35956159
http://dx.doi.org/10.3390/jcm11154543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369672/
https://www.ncbi.nlm.nih.gov/pubmed/35956159
http://dx.doi.org/10.3390/jcm11154543

Ejemplares similares